Source: Annual Congress 2001 - Inhalation devices and technique
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. E. Hesselink, B. W. J. H. Penninx, H. A. H. Wijnhoven, D. M. W. Kriegsman, J. T. M. van Eijk (Amsterdam, Maastricht, The Netherlands; Winston-Salem, United States Of America). Determinants of incorrect inhalation technique in patients with asthma and COPD. Eur Respir J 2001; 16: Suppl. 31, 533

Member's Comments

No comment yet.

Related content which might interest you: What influences the response to training of inhalation technique in patients with asthma and COPD? Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 Knowledge of asthma is associated with inhalation technique in elderly patients with asthma Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI Source: Virtual Congress 2020 – New imaging techniques applied to old problems Year: 2020 Screening of inhalation technique and treatment adherence of COPD, asthma and ACO patients Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019 Difference between asthma and COPD patients in adherence and non-adherence patterns to inhaler devices Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Preference of the inhaler device and assessment of the technique among the asthmatic and COPD patients Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011 Predictors of good inhaler technique in asthma and COPD Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 Differences in inhaler misuse between patients with asthma and COPD. Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 Continuous objective assessment of wheezing in adult asthma patients hospitalised following an acute exacerbation of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 267s Year: 2001 Study of the Glutoxim-containing inhalation treatment in bronchial asthma patients Source: Eur Respir J 2002; 20: Suppl. 38, 373s Year: 2002 Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Hair analysis to detect chronic inhaler drug use in asthma or COPD patients Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017 The effect of inhaler switching on asthma and COPD patients Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 Does the number of inhalers used by patients with asthma and COPD determine number of mistakes in inhalation technique? Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019 Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020 Tiotropium reduces asthma exacerbations in asthmatic patients with persistent airflow obstruction uncontrolled despite treatment in accordance with guidelines Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012 A pilot study of CPAP therapy for excessive dynamic airway collapse during acute exacerbation of COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014